Vimarsana
Biggest News Aggregation in the World

Morningside Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Morningside Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Morningside Ventures Today - Breaking & Trending Today

Curai Health to Expand Access to Care for Individuals - Vimarsana News

Curai Health to Expand Access to Care for Individuals

Curai Health and Healthcare in Action to expand access to care for individuals experiencing homelessness. ...

ENYO Pharma Announces a 39 Million Series C Financing and FDA Clearance to Advance Vonafexor in a Phase 2 Clinical Trial for Patients With Alport Syndrome - Vimarsana News

ENYO Pharma Announces a 39 Million Series C Financing and FDA Clearance to Advance Vonafexor in a Phase 2 Clinical Trial for Patients With Alport Syndrome

ENYO Pharma ENYO announced that it has received clearance of its Investigational New Drug IND application from the U.S. Food and Drug Administration FDA to initiate a Phase 2 clinical study of Vonafexor a highly selective FXR agonist for the treatment of Alport Syndrome.

AdaptX Secures $10M for AI-Powered, Self-Serve Clinical Management - Vimarsana News

AdaptX Secures $10M for AI-Powered, Self-Serve Clinical Management

AdaptX, a self-serve clinical management solution company raises $10M in funding led by Cercano Management and included participation from...

AdaptX Raises $10M In Funding - Vimarsana News

AdaptX Raises $10M In Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Angitia Biopharma snags $46m and 48 more Greater China deals worth $1b - Vimarsana News

Angitia Biopharma snags $46m and 48 more Greater China deals worth $1b

Previously, the firm bagged $70 million in a Series B funding round led by Morningside Ventures in October 2021.